Skip to NavigationSkip to content

Ned Sharpless

Donald Trump nominates Dr Stephen Hahn as next FDA Commissioner

The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s top pick to lead the regulatory agency.

Dr Stephen Hahn was announced as the Commander-in-Chief’s nomination for the role. Dr Hahn most recently served as the Chief Medical Executive at The University of Texas MD Anderson Cancer Center (MDACC) in Houston, Texas since May 2018, a patient care organisation employing around 21,000 staff; the firm also generates over $5 billion annually and conducts “the largest number of clinical trials in the United States”.

National Cancer Institute Director Ned Sharpless to become interim FDA Commissioner

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of the National Cancer Institute (NCI), has been announced by Health and Human Services Secretary Alex Azar as a temporary replacement to lead the FDA until a permanent Commissioner can be found.

The National Cancer Institute is a division of the National Institutes of Health, directing billions of federal funds and research grants. Dr Sharpless has led the organisation since October 2017.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches